Rock Creek Group’s Sanofi SNY Stock Holding History

Rock Creek Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$5K	–	232
2021 Q1	$5K	Buy	+100	New	+$4.8K	﹤0.01%	203

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Rock Creek Group's SNY Position: Q2 2021 in Review

Rock Creek Group sold out of Sanofi (SNY) in Q2 2021, closing a stake of 100 shares — an estimated $5K sold.

Rock Creek Group first reported a position in SNY in Q1 2021 and held it in 1 quarter. The position peaked at $5K in Q1 2021. 585 funds tracked by Wall St. Rank hold SNY as of Q2 2021.

Rock Creek Group reported no remaining Sanofi position as of Q2 2021 after selling out during the quarter.
Rock Creek Group sold 100 Sanofi shares in Q2 2021, an estimated $5K.
Rock Creek Group first reported a position in Sanofi in Q1 2021 and held it in 1 quarter.
Rock Creek Group's Sanofi position peaked at $5K in Q1 2021.
585 funds tracked by Wall St. Rank held Sanofi as of Q2 2021.

Based on Rock Creek Group's 13F filing for Q2 2021, filed 10 Aug 2021.